Hcyb1
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-132993-5MG | 5 mg | 393,00 | Add | |
| HY-132993-1ML | 10mM/1mL | 432,00 | Add | |
| HY-132993-10MG | 10 mg | 621,00 | Add | |
| HY-132993-25MG | 25 mg | 1'217,00 | Add | |
| HY-132993-50MG | 50 mg | 1'851,00 | Add | |
| HY-132993-100MG | 100 mg | 2'864,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Hcyb1 is a highly selective, orally active PDE2 inhibitor. Hcyb1 has a highly selective inhibition of PDE2A (IC50=0.57 μM) and over 250-fold selectivity against other recombinant PDE family members. Hcyb1 produces neuroprotective and antidepressant‐like effects most likely mediated by cAMP/cGMP-CREB-BDNF signaling[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Neurological Disease, Metabolic Enzyme/Protease |
| Format | Solubility: DMSO : 62.5 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 98.24% |
| Molecular Formula | C24H20N4O |
| Molecular Weight | 380.44 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
